Showing results (81-90 of 648) with videos related to
Sort By:
Pageof 65
Annals of Hematology|March 1, 1993
Dose-escalation study for the treatment of Hodgkin's disease. The German Hodgkin Study Group (GHSG)V DiehlLeber, Magen, Darm|October 1, 1977
[Cytostatic therapy of gastro-intestinal carcinomas (author's transl)]V DiehlSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1994
Controversies in terminal cancer careV DiehlEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Fractionated chemotherapy--granisetron or conventional antiemetics? The Granisetron Study GroupV DiehlBlood|November 8, 2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin diseaseM R Weihrauch, D Re, K Scheidhauer, et al.Bone Marrow Transplantation|July 22, 1999
Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilizationM Reiser, A Josting, A Draube, et al.Immunitat Und Infektion|November 1, 1979
[Origin and biological role of lipid mediators during inflammation (author's transl)]H Tesch, W KönigScandinavian Journal of Immunology|January 1, 1980
Phospholipase A2 and arachidonic acid: a common link in the generation of the eosinophil chemotactic factor (ECF) from human PMN by various stimuliH Tesch, W KönigThe American Journal of Pathology|November 5, 1997
Classical Hodgkin's disease. Clinical impact of the immunophenotypeR von Wasielewski, M Mengel, R Fischer, et al.Journal of Virology|January 9, 1999
Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428D Kube, M Vockerodt, O Weber, et al.Pageof 65